Abbott rakes in earnings despite infant formula investigation but Nutrition suffers sales loss
date:Jul 22, 2022
.4% sales loss.

Total worldwide Nutrition and Pediatric Nutrition sales were negatively impacted by a voluntary recall and manufacturing shutdown initiated in February of certain infant formula products manufactured at one of Abbotts US plants, Robert B. Ford, chairman and CEO, Abbott, tells.

Abbott Nutrition initiated a voluntary product recall in February after the US Food and Drug Administration (FDA) announced it was investigating consumer complaints linked to Cronobacter sakazakii. Since
2/11 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/19 15:48